NO20085087L - Nye heterocykliske forbindelser - Google Patents

Nye heterocykliske forbindelser

Info

Publication number
NO20085087L
NO20085087L NO20085087A NO20085087A NO20085087L NO 20085087 L NO20085087 L NO 20085087L NO 20085087 A NO20085087 A NO 20085087A NO 20085087 A NO20085087 A NO 20085087A NO 20085087 L NO20085087 L NO 20085087L
Authority
NO
Norway
Prior art keywords
heterocyclic compounds
new heterocyclic
derivatives
pyridinone
pyridone
Prior art date
Application number
NO20085087A
Other languages
English (en)
Norwegian (no)
Inventor
Jose Maria Bueno Calderon
Jesus Chicharro Gonzalo
Milagros Lorenzo Garcia
M Pilar Manzano Chinchon
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06381025A external-priority patent/EP1862459A1/en
Priority claimed from EP07380072A external-priority patent/EP1967515A1/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20085087L publication Critical patent/NO20085087L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20085087A 2006-05-31 2008-12-05 Nye heterocykliske forbindelser NO20085087L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06381025A EP1862459A1 (en) 2006-05-31 2006-05-31 Novel heterocyclic compounds
EP07380072A EP1967515A1 (en) 2007-03-08 2007-03-08 Heterocyclic compounds
PCT/EP2007/055188 WO2007138048A1 (en) 2006-05-31 2007-05-29 Novel heterocyclic compounds

Publications (1)

Publication Number Publication Date
NO20085087L true NO20085087L (no) 2009-02-20

Family

ID=38480438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085087A NO20085087L (no) 2006-05-31 2008-12-05 Nye heterocykliske forbindelser

Country Status (17)

Country Link
US (2) US7674808B2 (OSRAM)
EP (1) EP2024332A1 (OSRAM)
JP (1) JP2009538873A (OSRAM)
KR (1) KR20090012342A (OSRAM)
AR (1) AR060974A1 (OSRAM)
AU (1) AU2007267093A1 (OSRAM)
BR (1) BRPI0711783A2 (OSRAM)
CA (1) CA2653872A1 (OSRAM)
CR (1) CR10492A (OSRAM)
EA (1) EA200870545A1 (OSRAM)
IL (1) IL195158A0 (OSRAM)
MA (1) MA30487B1 (OSRAM)
MX (1) MX2008015291A (OSRAM)
NO (1) NO20085087L (OSRAM)
PE (1) PE20080453A1 (OSRAM)
TW (1) TW200817331A (OSRAM)
WO (1) WO2007138048A1 (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
WO2006130188A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic bifidobacteria
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
CN101711158A (zh) 2007-02-01 2010-05-19 爱默思公司 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
CN101932561A (zh) * 2007-11-30 2010-12-29 葛兰素集团有限公司 抗疟疾化合物的晶型
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
WO2010081904A1 (en) 2009-01-19 2010-07-22 Glaxo Group Limited 4 ( 1h) -pyridinone derivatives and their use as antimalaria agents
EP2246329A1 (en) 2009-01-19 2010-11-03 Glaxo Group Limited 4(1H)-pyridinone derivatives and their use as antimalaria agents
TW201039834A (en) 2009-02-20 2010-11-16 Glaxo Group Ltd Novel heterocyclic compounds
WO2010142741A1 (en) * 2009-06-12 2010-12-16 Glaxo Group Limited Phenylpyridylpyridones for use as antimalarial agents
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US10426476B2 (en) * 2014-09-26 2019-10-01 Ethicon Llc Circular fastener cartridges for applying radially expandable fastener lines
JOP20180072A1 (ar) 2014-09-11 2019-01-30 Lilly Co Eli علاج الأعراض المرتبطة بالعلاج بالحرمان من الأندروجين
WO2016169908A1 (en) * 2015-04-21 2016-10-27 Glaxosmithkline Intellectual Property Development Limited Uracil derivatives for the treatment of malaria
GB201809627D0 (en) * 2018-06-12 2018-07-25 Biorelevant Com Ltd Methods for preparing buffer solutions suitable for in vitro drug dissolution testing, drug solubility testing and/or drug profiling

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403934A (en) * 1990-03-12 1995-04-04 Burroughs Wellcome Co. Heterocyclic compounds
GB9005518D0 (en) * 1990-03-12 1990-05-09 Wellcome Found Heterocyclic compounds
GB9100465D0 (en) * 1991-01-09 1991-02-20 Hider Robert C Pharmaceutical compositions

Also Published As

Publication number Publication date
US20070281977A1 (en) 2007-12-06
TW200817331A (en) 2008-04-16
US20080021073A1 (en) 2008-01-24
US7674808B2 (en) 2010-03-09
EP2024332A1 (en) 2009-02-18
MX2008015291A (es) 2008-12-12
AR060974A1 (es) 2008-07-23
BRPI0711783A2 (pt) 2011-11-29
CA2653872A1 (en) 2007-12-06
EA200870545A1 (ru) 2009-12-30
PE20080453A1 (es) 2008-05-29
CR10492A (es) 2009-01-27
WO2007138048A1 (en) 2007-12-06
AU2007267093A1 (en) 2007-12-06
MA30487B1 (fr) 2009-06-01
JP2009538873A (ja) 2009-11-12
IL195158A0 (en) 2009-08-03
KR20090012342A (ko) 2009-02-03
US7629365B2 (en) 2009-12-08

Similar Documents

Publication Publication Date Title
NO20085087L (no) Nye heterocykliske forbindelser
NO20066055L (no) Pyridinderivater
NO20074703L (no) Antibakterielle piperidinderivater
NO20071593L (no) Pyrimidinderivater
SE0202463D0 (sv) Novel compounds
DE60322359D1 (de) Imidazopyridinderivate als kinaseinhibitoren
NO20063231L (no) Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20075059L (no) Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase
NO20091553L (no) Fenylderivater og deres anvendelse som immunmodulatorer
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
PL378064A1 (pl) Pirymidyny i triazyny hamujące replikację wirusa HIV
NO20064166L (no) Utvalgte CGRP-antagonister, deres fremstilling og deres anvendelse som medikanmenter
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
NO20051695L (no) Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer
NO20081001L (no) Derivater av karboksamid som antagonister for muskarinisk reseptor
UA94065C2 (en) Dihydropseudoerythromycin derivatives
SE0402762D0 (sv) Indazole sulphonamide derivatives
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
GB0308201D0 (en) Novel compounds
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0301699D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
NO20070157L (no) Substituerte diketopiperaziner som oksytocinantagonister
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application